Woodline Partners LP Spring Works Therapeutics, Inc. Transaction History

Woodline Partners LP

$14.3 Billion
Q1 2025

A detailed history of Woodline Partners LP transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 2,144,814 shares of SWTX stock, worth $98.8 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares

2,144,814

Previous 1,490,136 43.93%

Holding current value

$98.8 Million

Previous $53.8 Million 75.81%

% of portfolio

0.66%

Previous 0.4%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$32.5 - $59.93 $21.3 Million - $39.2 Million	654,678 Added 43.93%	2,144,814 $94.7 Million
Q4 2024 Feb 14, 2025	BUY	$28.61 - $42.55 $3.1 Million - $4.62 Million	108,512 Added 7.85%	1,490,136 $53.8 Million
Q3 2024 Nov 14, 2024	BUY	$32.04 - $42.76 $615,969 - $822,061	19,225 Added 1.41%	1,381,624 $44.3 Million
Q2 2024 Aug 14, 2024	BUY	$36.06 - $47.62 $17.9 Million - $23.6 Million	495,175 Added 57.1%	1,362,399 $51.3 Million
Q1 2024 May 15, 2024	BUY	$36.5 - $52.5 $2.37 Million - $3.41 Million	65,042 Added 8.11%	867,224 $42.7 Million
Q4 2023 Feb 14, 2024	BUY	$18.94 - $37.24 $11.6 Million - $22.7 Million	610,809 Added 319.17%	802,182 $29.3 Million
Q3 2023 Nov 14, 2023	BUY	$23.12 - $31.38 $1.03 Million - $1.39 Million	44,373 Added 30.19%	191,373 $4.42 Million
Q2 2023 Aug 14, 2023	SELL	$23.15 - $32.71 $30.1 Million - $42.5 Million	-1,300,389 Reduced 89.84%	147,000 $3.85 Million
Q1 2023 May 15, 2023	BUY	$24.97 - $34.05 $36.1 Million - $49.3 Million	1,447,389 New	1,447,389 $37.3 Million
Q2 2022 Aug 15, 2022	SELL	$18.36 - $60.07 $4.28 Million - $14 Million	-233,210 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$48.97 - $65.46 $450,034 - $601,577	-9,190 Reduced 3.79%	233,210 $13.2 Million
Q4 2021 Feb 14, 2022	BUY	$53.3 - $75.84 $12.2 Million - $17.4 Million	229,074 Added 1719.0%	242,400 $15 Million
Q3 2021 Nov 15, 2021	SELL	$62.66 - $88.26 $5.15 Million - $7.25 Million	-82,132 Reduced 86.04%	13,326 $845,000
Q2 2021 Aug 16, 2021	SELL	$67.45 - $85.63 $5.39 Million - $6.84 Million	-79,870 Reduced 45.55%	95,458 $7.87 Million
Q1 2021 May 17, 2021	BUY	$65.1 - $93.59 $2.96 Million - $4.26 Million	45,496 Added 35.04%	175,328 $12.9 Million
Q4 2020 Feb 16, 2021	SELL	$48.36 - $77.92 $4.48 Million - $7.21 Million	-92,544 Reduced 41.62%	129,832 $9.42 Million
Q3 2020 Nov 16, 2020	BUY	$36.14 - $51.99 $2.16 Million - $3.11 Million	59,861 Added 36.83%	222,376 $10.6 Million
Q2 2020 Aug 14, 2020	SELL	$22.98 - $48.57 $1.11 Million - $2.35 Million	-48,378 Reduced 22.94%	162,515 $6.83 Million
Q1 2020 May 15, 2020	BUY	$20.44 - $41.21 $4.31 Million - $8.69 Million	210,893 New	210,893 $5.69 Million

Others Institutions Holding SWTX

# of Institutions

349

Shares Held

62.3M

Call Options Held

5.66M

Put Options Held

2.51M

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.88B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account

Woodline Partners LP Spring Works Therapeutics, Inc. Transaction History